U.S. Infant Mortality Rate Reaches All-Time Low in 2025

Preliminary government data for 2025 indicates that the U.S. infant mortality rate has fallen to a new all-time low. The Centers for Disease Control and Prevention (CDC) reported slightly fewer than 5.4 infant deaths per 1,000 live births. Despite this record low, the U.S. rate continues to trail behind those of other similar nations.

By Fainaron·Jun 16, 2026 (an hour ago)·1 views

U.S. Infant Mortality Rate Reaches All-Time Low in 2025

The United States recorded its lowest infant mortality rate in 2025, according to preliminary government data. The Centers for Disease Control and Prevention (CDC) announced that there were slightly fewer than 5.4 infant deaths per 1,000 live births during the year.

This marks a significant milestone in public health for the nation. However, despite reaching this all-time low, the U.S. infant mortality rate still remains higher than that of other comparable developed nations.

According to STAT News, this data highlights both an improvement in U.S. health outcomes and a persistent disparity when compared internationally.

#infant mortality #public health #cdc #united states #health statistics #child health

Source attribution: This article was AI-curated and rewritten by Fainaron from a piece originally published by STAT News. Read the original at STAT News →

More like this

Many Patients Stop GLP-1 Drugs for Type 2 Diabetes But Often Return to Treatment

Health

11 minutes ago

Many Patients Stop GLP-1 Drugs for Type 2 Diabetes But Often Return to Treatment

Many individuals prescribed GLP-1 drugs for type 2 diabetes, including medications like Victoza, Ozempic, or tirzepatide, frequently discontinue their use. Researchers have observed that a notable number of these patients later resume treatment. While side effects remain a primary reason for discontinuation, newer GLP-1 medications appear to encourage patients to stay on therapy for longer durations.

Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes Patients

A recent real-world study suggests that semaglutide, known by brand names such as Ozempic, Wegovy, and Rybelsus, may offer an added benefit for individuals with type 2 diabetes. The research indicates that patients using semaglutide experienced fewer bone fractures even while achieving more significant weight loss. The study, which analyzed health records from nearly 60,000 adults, found that those on semaglutide had approximately 15% fewer fractures compared to individuals taking other common weight-loss medications.

Science Daily

U.S. Infant Mortality Reaches All-Time Low in 2025

Health

20 minutes ago

U.S. Infant Mortality Reaches All-Time Low in 2025

Preliminary government data indicates that the infant mortality rate in the United States fell to a new all-time low in 2025, with slightly fewer than 5.4 infant deaths per 1,000 live births. This decline is statistically significant, representing hundreds fewer infant deaths annually. The improvement follows recommendations for new preventative measures introduced in 2023, including antibody shots for infants and RSV vaccines for pregnant women. Despite this progress, the U.S. infant mortality rate remains higher than that of other high-income countries.

Fortune

HHS, NASA Launch Challenge for Medical Supply Chain Resilience

Health

an hour ago

HHS, NASA Launch Challenge for Medical Supply Chain Resilience

The U.S. Department of Health and Human Services (HHS), through its Administration for Strategic Preparedness and Response (ASPR), has launched a prize competition aimed at strengthening the nation's ability to rapidly produce and distribute critical medical supplies. NASA’s Center of Excellence for Collaborative Innovation (CoECI) is assisting in this crowdsourced challenge, which seeks forward-thinking solutions for resilient medical manufacturing, logistics, and digital coordination during public health emergencies. The multi-phase challenge offers a total prize purse of up to $2.04 million.

NASA Breaking News

Back to Homepage

U.S. Infant Mortality Rate Reaches All-Time Low in 2025

More like this

Many Patients Stop GLP-1 Drugs for Type 2 Diabetes But Often Return to Treatment

Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes Patients

U.S. Infant Mortality Reaches All-Time Low in 2025

HHS, NASA Launch Challenge for Medical Supply Chain Resilience

Fainaron — live counters